Over the past two months, more than 30 pharmaceutical company executives have resigned, and the 67-year-old Asian richest man has resigned

On February 8, Renfu Medicine announced that Mr.
Xu Huabin had applied for resignation from the position of vice president of the company due to personal reasons.
The resignation report became effective from the date of delivery to the company’s board of directors.
After resignation, he would no longer hold any position in the company
.

 Eddie Pharmaceuticals: Deputy General Manager resigns

On February 8, Aidi Pharmaceuticals issued an announcement stating that Mr.
Marseille had applied for resignation from the position of deputy general manager of the company due to personal reasons, and the resignation report became effective from the date of delivery to the board of directors
.
After Mr.
Marseille resigns, he will no longer hold any position in the company, and his marketing business will be in charge of the company's deputy general manager, Mr.
Wang Jun
.

Tailin Bio: The chairman of the company's board of supervisors resigns

On February 8, Tailin Biotechnology issued an announcement that Ms.
Fang Xiaoyan, due to personal reasons, applied to resign as a supervisor of the company's board of supervisors and chairman of the board of supervisors.
After resignation, Ms.
Fang Xiaoyan will no longer hold the position of the company
.
According to relevant regulations, Ms.
Fang Xiaoyan's application for resignation will take effect after the election of a new supervisor at the general meeting of shareholders
.
During this period, Ms.
Fang Xiaoyan will continue to perform supervisory duties in accordance with relevant regulations
.

 Foci Pharmaceutical: Deputy General Manager resigns

On February 5, Foci Pharmaceuticals announced that Mr.
Wang Xinhai had applied for resignation from the position of deputy general manager of the company due to job transfer.
After resignation, he would no longer hold any position in the company or its subsidiaries
.
According to relevant regulations, Mr.
Wang Xinhai's resignation report will take effect when it is delivered to the board of directors
.

Erkang Pharmaceutical: Resignation of Supervisor

On February 5, Erkang Pharmaceutical issued an announcement stating that Mr.
Zhou Fujun had applied to resign from the position of the company's supervisor and chairman of the board of supervisors due to personal reasons, and would no longer hold any position in the company after resignation
.
Before the appointment of the new supervisor, Mr.
Zhou Fujun will still perform his duties as a supervisor in accordance with relevant laws, regulations and the "Articles of Association"
.

China Medicine: Chairman resigns

On February 2, China Pharmaceuticals issued an announcement stating that due to work adjustments, Mr.
Gao Yuwen had applied for the resignation of the company's chairman (legal representative), directors and relevant positions of the board's special committees, and his resignation application took effect from the date of delivery to the company's board of directors
.
Mr.
Gao Yuwen will no longer hold any position in the company, and the company will complete the election of new directors and chairman of the board in accordance with legal procedures as soon as possible
.

 Nanxin Pharmaceutical: core technical personnel resign

On February 1, Nanxin Pharmaceutical announced that its core technical staff, Mr.
Miao Dong, had recently applied for resignation due to personal reasons and completed the resignation procedures
.
After resignation, Mr.
Miao Dong will not hold any position in the company
.

Hainan Haiyao: The chairman and general manager of the company resign

On January 29, Hainan Haiyao Co.
, Ltd.
issued an announcement that Mr.
Cheng Aimin applied for the resignation of the company's chairman, director, convener of the strategy committee and member of the nomination committee due to work adjustments
.
After resignation, Mr.
Cheng Aimin will no longer hold any position in the company
.

Mr.
Liu Xicheng applied to resign from the position of general manager of the company due to personal reasons.
After his resignation, Mr.
Liu Xicheng will continue to serve as the vice chairman of the company, a member of the strategy committee of the board of directors, and a member of the remuneration and assessment committee of the board of directors
.

The resignation reports of Mr.
Cheng Aimin and Mr.
Liu Xicheng took effect from the date they were delivered to the company’s board of directors
.

Zhongxin Pharmaceutical: Senior management resigns

On January 29, China New Medicine announced that the company had received a written resignation from Mr.
Ni Zhenguo, and that Mr.
Ni Zhenguo applied for resignation from the position of deputy general manager of the company due to job changes
.
After resignation, Mr.
Ni Zhenguo no longer holds any position in the company
.

Jinling Pharmaceutical: The company's senior management resigns

On January 28, Jinling Pharmaceutical announced that Mr.
Yin Jianbiao had requested to resign from the company's chief economist due to personal health reasons
.
According to relevant regulations, Mr.
Yin Jianbiao’s resignation report will take effect from the day it is delivered to the company’s board of directors
.
After resignation, Mr.
Yin Jianbiao ceased to hold any position in the company
.

 Oriental Bio: Director resigns

On January 28, Eastern Biotech announced that it would receive a written resignation report from director Ms.
Ye Su on January 27, 2021
.
Due to personal work reasons, Ms.
Ye Su applied to resign as a director of the company's second board of directors.
After resignation, she will not hold any position in the company
.
His resignation will take effect when the resignation report is delivered to the board of directors
.

Ruikang Pharmaceutical: company executives resign

On January 26, Ruikang Pharmaceutical announced that it had recently received a written resignation report from the company’s deputy general manager, Mr.
Qin Xiaohua, and proposed to resign from the company’s deputy general manager due to his personal reasons
.
Mr.
Qin Xiaohua’s resignation report will be effective as soon as it is delivered to the company’s board of directors, and Mr.
Qin Xiaohua will no longer hold any other positions in the company after his resignation
.

 Tianmushan Pharmaceutical: The company's deputy general manager resigns

On January 25, Hangzhou Tianmushan Pharmaceutical issued an announcement stating that Mr.
Cheng Haibo had applied for resignation from the position of deputy general manager of the company due to personal reasons
.
After resignation, Mr.
Cheng Haibo no longer holds any position in the company
.

Guang Yuyuan: Director and senior management resign

On January 21, Guang Yuyuan issued an announcement stating that Mr.
Yang Hongfei applied to resign from the company's director, executive vice president and member of the audit committee of the board due to job change, and Ms.
Zheng Yanli applied to resign from the company's director and vice president due to job change
.

After resignation, Mr.
Yang Hongfei and Ms.
Zheng Yanli will not hold any positions in the company, and their resignation applications will take effect when the "resignation report" is delivered to the board of directors
.

Guizhou Sanli: Deputy General Manager resigns

On January 21, Guizhou Sanli Pharmaceutical issued an announcement that Mr.
Fan Xiaobo and Mr.
Xie Zhen applied for resignation from the position of deputy general manager of the company due to personal reasons, and will no longer hold other positions in the company after resignation
.
The resignation reports of the two men took effect from the day they were delivered to the board of directors
.

In addition, the announcement stated that Mr.
Zhou Xianning and Ms.
Guo Ke were agreed to be appointed as the company's deputy general managers.
The term of office is from the date of the resolution of the board of directors to the expiration of the company's second board of directors
.

 Si Taili: Deputy General Manager resigned

On January 18, Stellite announced that Mr.
Zhou Hu had applied for resignation from the position of deputy general manager of the company due to personal reasons
.
After resignation, Mr.
Zhou Hu no longer holds any position in the company and related subsidiaries
.

Dali Pharmaceutical: The company's deputy general manager resigns

On January 15, Dali Pharmaceutical announced that Mr.
Chen Ge had resigned from the position of deputy general manager of the company due to personal reasons.
After resignation, Mr.
Chen Ge will not hold any position in the company
.

 Wantai Bio: Chairman resigns

On January 13, Beijing Wantai Biotechnology issued an announcement that Mr.
Zhong Suisui resigned from the position of director and chairman of the company due to personal reasons.
At the same time, he resigned from the positions of convener of the strategy committee of the company's board of directors and convener of the nomination committee of the board of directors.
Mr.
Zhong Suisui resigned Will no longer hold any position in the company
.
His resignation shall take effect from the date when the resignation report is delivered to the company's board of directors
.

 Hyundai Pharmaceutical: Director resigns

On January 13, Shanghai Modern Pharmaceutical announced that Vice Chairman Li Zhiming would no longer serve as a director, vice chairman and member of the strategy and investment committee of the company's seventh board of directors due to personal reasons
.
After resignation, Mr.
Li Zhiming will not hold any position in the company
.

Innovative medical treatment: company vice president resigns

On January 13, Innovative Medical issued an announcement that Mr.
Ma Tao applied to resign from the position of vice president of the company due to personal reasons.
After his resignation, Mr.
Ma Tao will no longer hold any position in the company
.

Sinopharm: resignation of director and general manager

On January 12, Sinopharm announced that due to personal reasons, Mr.
Li Hui resigned from the posts of director, general manager, member of the strategy committee and member of the audit committee of Sinopharm.
The resignation took effect immediately
.

 Shouxiangu: Resignation of Independent Director

On January 11, Zhejiang Shouxiangu Pharmaceutical announced that Mr.
Wang Xue had resigned from the position of independent director of the company, member of the remuneration and assessment committee of the board of directors, member of the strategy committee of the board of directors, and member of the nomination committee of the board of directors due to personal reasons
.
After Mr.
Wang Xue resigned, he no longer holds any position in the company
.

.
According to relevant regulations, Mr.
Wang Xue will continue to perform his duties until the date when the new independent director is appointed
.

 Haite Bio: Resignation of directors and independent directors

On January 6, the board of directors of Haite Biotechnology received a written resignation report submitted by director Ye Weitao
.
Due to personal reasons, Mr.
Ye Weitao applied to resign from his position as a director of the company and at the same time resigned as a member of the Strategy Committee of the Board of Directors
.
After resignation, Mr.
Ye Weitao no longer holds any position in the company
.
The resignation report shall take effect from the day it is delivered to the board of directors
.

On the same day, Haite Biological announced that the independent directors, Ms.
Li Changai and Mr.
Chen Yong, have served as independent directors in the company for six consecutive years.
According to relevant regulations, Ms.
Li Changai and Mr.
Chen Yong no longer serve as independent directors of the company, and Ms.
Li Changai is at the same time.
Mr.
Chen Yong also resigned as a member of the audit committee and convener of the remuneration and appraisal committee of the company's board of directors
.
After leaving office, Ms.
Li Changai and Mr.
Chen Yong will not hold any positions in the company
.

Jincheng Pharmaceutical: General Manager resigns

On January 4, Jincheng Pharmaceutical announced that Mr.
Zhang Xuebo had applied for the resignation of the company’s general manager and member of the Remuneration and Appraisal Committee due to his personal age.
The resignation report will take effect from the date of delivery to the company’s board of directors.
After his resignation, Mr.
Zhang Xuebo will still serve as the company’s deputy director.
Long
.

Eli Lilly: CFO resigns

On February 9, local time, Eli Lilly announced the personnel change of the chief financial officer position.
The former CFO Josh Smiley had resigned due to misconduct and reached a resignation agreement with the company
.

In addition, Eli Lilly announced the appointment of Anat Ashkenazi to succeed the company's senior vice president and CFO.
She was previously the head and chief financial officer of Eli Lilly's research laboratory
.